from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2220/glnA1

LFCtreatmentdescriptionclass of inhibitor

-0.453

Amikacinug/mL Amikacintranslation

-0.534

Cap5-10ug/mL Capreomycintranslation

-1.366

Rox10-50 ug/mL Roxithromycintranslation

0.407

SM2-5 ug/mL Streptomycintranslation

-1.095

Tet5-10 ug/mL Tetracyclinetranslation

-0.481

Rif0.2-5ug/mL Rifampicintranscription

-0.536

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.742

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.665

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.622

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.680

Clofazimine10-13 ug/mL Clofaziminerespiration

0.301

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.904

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.613

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.533

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.226

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.106

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.229

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.733

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.147

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.866

KCN5-20 ug/mL Potassium cyaniderespiration

-0.487

NaN30.2-2 mM Sodium aziderespiration

0.734

Nigericin50 uM Nigericinrespiration

-1.271

TRC10-150 ug/mL Triclosanrespiration

-1.308

TRZ10-25 ug/mL Thioridazinerespiration

-1.356

Valinomycin0.5-10 uM Valinomycinrespiration

1.235

ZnSO42 mM ZnSO4respiration

-0.024

menadione6-10 ug/mL Menadionerespiration

0.277

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.860

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.754

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.047

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.284

NRP_1Non-replicating persistence stage 1dosRassociated

0.491

Amp0.2mg/mL AmpicillincellWall

0.833

Cephalexin20-100 ug/mL CephalexincellWall

0.846

Cerulenin0.32-5 ug/mL CerulenincellWall

0.220

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.297

EMB10-20 ug/mL EthambutolcellWall

0.427

Eta12-40 ug/mL EthionamidecellWall

0.228

INH0.2-0.4 ug/mL IsoniazidcellWall

0.501

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.726

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.691

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.262

BZA0.12 mg/mL BenzamidearomaticAmides

-0.186

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.255

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.017

H2O24 mM hydrogen peroxideDNAdamaging

0.182

Levo10 ug/mL LevofloxacinDNAdamaging

1.003

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.732

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.137

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.957

UVUV-irradiationDNAdamaging

-0.177

ARP41-4 ug/mL Antitubercular compound ARP4?

1.053

Antimycin12.5-50 ug/mL Antimycin A?

0.865

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.542

PA_110-50 ug/mL Antitubercular compound PA-1?

0.904

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.109

PA8240.2-2 ug/mL PA-824?

-1.708

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.075

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.324

Verapamil50 uM Verapamil?

1.003

mercaptoethanol2 mM 2-Mercaptoethanol?

0.911

methoxatin10-20 ug/mL Methoxatin?